Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Smith

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
BJU International|October 10, 2007
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scannerAnurag K Singh, Axel Krieger, Jean-Baptiste Lattouf, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2007
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC scoreNicole L Simone, Cynthia Ménard, Benjamin P Soule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancyEdward J Licitra, Viral Vyas, Kathy Nelson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot studyAnurag K Singh, Cynthia Ménard, Peter Guion, et al.
Radiation Oncology (London, England)|August 18, 2006
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boostAnurag K Singh, Peter Guion, Robert C Susil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Urine analysis and protein networking identify met as a marker of metastatic prostate cancerAndrea L Russo, Kimberly Jedlicka, Meredith Wernick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
MRI-guided HDR prostate brachytherapy in standard 1.5T scannerCynthia Ménard, Robert C Susil, Peter Choyke, et al.
Human Antibodies|December 24, 2010
A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivoTim Ebert, Sharon Smith, Greg Pancari, et al.
Human Genetics|April 7, 2016
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic featuresVolkan Okur, Megan T Cho, Lindsay Henderson, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
BJU International|October 10, 2007
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scannerAnurag K Singh, Axel Krieger, Jean-Baptiste Lattouf, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2007
Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC scoreNicole L Simone, Cynthia Ménard, Benjamin P Soule, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancyEdward J Licitra, Viral Vyas, Kathy Nelson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2009
Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancerDeborah Citrin, John Mansueti, Anna Likhacheva, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot studyAnurag K Singh, Cynthia Ménard, Peter Guion, et al.
Radiation Oncology (London, England)|August 18, 2006
Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boostAnurag K Singh, Peter Guion, Robert C Susil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Urine analysis and protein networking identify met as a marker of metastatic prostate cancerAndrea L Russo, Kimberly Jedlicka, Meredith Wernick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
MRI-guided HDR prostate brachytherapy in standard 1.5T scannerCynthia Ménard, Robert C Susil, Peter Choyke, et al.
Human Antibodies|December 24, 2010
A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivoTim Ebert, Sharon Smith, Greg Pancari, et al.
Human Genetics|April 7, 2016
De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic featuresVolkan Okur, Megan T Cho, Lindsay Henderson, et al.
Pageof 8